normalized two dimensional cross-correlation functions Search Results


99
ATCC normal mammary gland epithelial
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Normal Mammary Gland Epithelial, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normal mammary gland epithelial/product/ATCC
Average 99 stars, based on 1 article reviews
normal mammary gland epithelial - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
MathWorks Inc cross-correlation
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Cross Correlation, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cross-correlation/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
cross-correlation - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MathWorks Inc normalized two dimensional cross-correlation functions
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Normalized Two Dimensional Cross Correlation Functions, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/normalized two dimensional cross-correlation functions/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
normalized two dimensional cross-correlation functions - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
TRICOR Systems two-dimensional cross-correlation algorithm todcor
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Two Dimensional Cross Correlation Algorithm Todcor, supplied by TRICOR Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two-dimensional cross-correlation algorithm todcor/product/TRICOR Systems
Average 90 stars, based on 1 article reviews
two-dimensional cross-correlation algorithm todcor - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MathWorks Inc two-dimensional cross-correlation algorithm
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Two Dimensional Cross Correlation Algorithm, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two-dimensional cross-correlation algorithm/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
two-dimensional cross-correlation algorithm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MathWorks Inc two-dimensional cross-correlation algorithm matlab function xcorr2
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Two Dimensional Cross Correlation Algorithm Matlab Function Xcorr2, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two-dimensional cross-correlation algorithm matlab function xcorr2/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
two-dimensional cross-correlation algorithm matlab function xcorr2 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MathWorks Inc two dimensional cross-correlations
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Two Dimensional Cross Correlations, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/two dimensional cross-correlations/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
two dimensional cross-correlations - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Vingmed AS echocardiography vivid e9
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Echocardiography Vivid E9, supplied by Vingmed AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/echocardiography vivid e9/product/Vingmed AS
Average 90 stars, based on 1 article reviews
echocardiography vivid e9 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology echocardiography
Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland <t>epithelial</t> cells (MCF <t>10A)</t> analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.
Echocardiography, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/echocardiography/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
echocardiography - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
Galectin Therapeutics galectin-3
<t> Echocardiography parameters </t> used to diagnose systolic and diastolic left ventricular dysfunction on day 1, 30 and 180, in patients with and without left ventricular remodelling, six months after acute myocardial infarction.
Galectin 3, supplied by Galectin Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/galectin-3/product/Galectin Therapeutics
Average 90 stars, based on 1 article reviews
galectin-3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MathWorks Inc crosscorr function
<t> Echocardiography parameters </t> used to diagnose systolic and diastolic left ventricular dysfunction on day 1, 30 and 180, in patients with and without left ventricular remodelling, six months after acute myocardial infarction.
Crosscorr Function, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/crosscorr function/product/MathWorks Inc
Average 90 stars, based on 1 article reviews
crosscorr function - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
ABBELIGHT cross-correlation drift correction algorithm
<t> Echocardiography parameters </t> used to diagnose systolic and diastolic left ventricular dysfunction on day 1, 30 and 180, in patients with and without left ventricular remodelling, six months after acute myocardial infarction.
Cross Correlation Drift Correction Algorithm, supplied by ABBELIGHT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cross-correlation drift correction algorithm/product/ABBELIGHT
Average 90 stars, based on 1 article reviews
cross-correlation drift correction algorithm - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland epithelial cells (MCF 10A) analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.

Journal: Frontiers in Oncology

Article Title: Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway

doi: 10.3389/fonc.2022.712475

Figure Lengend Snippet: Expression of SLC16A1-AS1 is significantly downregulated in breast cancer (BC) cells and tissues and related to the prognosis of BC patients. (A) Bioinformatics analysis found downregulated SLC16A1-AS1 and MEG3 but upregulated HOTAIR expressions in tumor (T) tissues versus normal (N) tissues of BC (BRCA) patients by investigating the TCGA datasets using the online tool GEPIA. (B) SLC16A1-AS1 and MEG3 expressions were meaningfully downregulated, while HOTAIR expression was meaningfully upregulated in BC tissues versus paracancerous tissues from 80 BC patients analyzed by the qRT-PCR assay. (C) SLC16A1-AS1 expression was meaningfully lower in human BC (MCF7, MDA-MB-231, MB453, and BT474) than in human normal mammary gland epithelial cells (MCF 10A) analyzed with qRT-PCR, and the difference was most significant in MCF7 and MDA-MB-231 cells. (D, E) Analyzed by the Kaplan–Meier method among the 80 BC patients, lower SLC16A1-AS1 expression indicated a poor prognosis both in overall survival (D) and disease-free survival (E) . * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: A human normal mammary gland epithelial (MCF 10A) and four human BC (MCF7, MDA-MB-231, MB453, and BT474) cell lines were provided by the American Type Culture Collection (Manassas, USA) and maintained in DMEM containing 100 μg/ml streptomycin, 100 U/ml penicillin, and 10% FBS in a 37°C incubator with 5% CO 2 .

Techniques: Expressing, Quantitative RT-PCR

SLC16A1-AS1 increases WIF1 expression via sponging miR-552-5p. (A) Illustration of the prospective binding sites of miR-552-5p in WIF1 3′-UTR predicted with miRanda ( http://www.microrna.org/ ). (B) mRNA expression of WIF1 was significantly lower in BC cells (MDA-MB-231 and MCF7) than in normal mammary gland epithelial cells (MCF 10A) analyzed by qRT-PCR. (C) Dual-luciferase activities in MDA-MB-231 and MCF7 cells with negative control (NC), wild type (WT), or mutated (mut) reporter of WIF1 3′-UTR with miR-552-5p or without (NC) miR-552-5p mimics. (D) mRNA and protein expressions of WIF1 in MCF7 and MDA-MB-231 cells after miR-552-5p was silenced (miR-552-5p inhibitor) or overexpressed (miR-552-5p mimics). (E) mRNA (left panel) and protein expressions (middle and right panels) of WIF1 in SLC16A1-AS1 overexpressed in MDA-MB-231 and MCF7 cells with or without co-transfecting miR-552-5p. (F) Spearman correlation assay of the correlation between WIF1 and SLC16A1-AS1 or miR-552-5p in BC tissues from 80 BC patients (the same specimens used in <xref ref-type= Figure 1A ). * p < 0.05, ** p < 0.01, *** p < 0.001. " width="100%" height="100%">

Journal: Frontiers in Oncology

Article Title: Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway

doi: 10.3389/fonc.2022.712475

Figure Lengend Snippet: SLC16A1-AS1 increases WIF1 expression via sponging miR-552-5p. (A) Illustration of the prospective binding sites of miR-552-5p in WIF1 3′-UTR predicted with miRanda ( http://www.microrna.org/ ). (B) mRNA expression of WIF1 was significantly lower in BC cells (MDA-MB-231 and MCF7) than in normal mammary gland epithelial cells (MCF 10A) analyzed by qRT-PCR. (C) Dual-luciferase activities in MDA-MB-231 and MCF7 cells with negative control (NC), wild type (WT), or mutated (mut) reporter of WIF1 3′-UTR with miR-552-5p or without (NC) miR-552-5p mimics. (D) mRNA and protein expressions of WIF1 in MCF7 and MDA-MB-231 cells after miR-552-5p was silenced (miR-552-5p inhibitor) or overexpressed (miR-552-5p mimics). (E) mRNA (left panel) and protein expressions (middle and right panels) of WIF1 in SLC16A1-AS1 overexpressed in MDA-MB-231 and MCF7 cells with or without co-transfecting miR-552-5p. (F) Spearman correlation assay of the correlation between WIF1 and SLC16A1-AS1 or miR-552-5p in BC tissues from 80 BC patients (the same specimens used in Figure 1A ). * p < 0.05, ** p < 0.01, *** p < 0.001.

Article Snippet: A human normal mammary gland epithelial (MCF 10A) and four human BC (MCF7, MDA-MB-231, MB453, and BT474) cell lines were provided by the American Type Culture Collection (Manassas, USA) and maintained in DMEM containing 100 μg/ml streptomycin, 100 U/ml penicillin, and 10% FBS in a 37°C incubator with 5% CO 2 .

Techniques: Expressing, Binding Assay, Quantitative RT-PCR, Luciferase, Negative Control, Two-Photon Excitation Fluorescence Cross-Correlation Assay

 Echocardiography parameters  used to diagnose systolic and diastolic left ventricular dysfunction on day 1, 30 and 180, in patients with and without left ventricular remodelling, six months after acute myocardial infarction.

Journal: Scientific Reports

Article Title: Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction

doi: 10.1038/s41598-019-49511-4

Figure Lengend Snippet: Echocardiography parameters used to diagnose systolic and diastolic left ventricular dysfunction on day 1, 30 and 180, in patients with and without left ventricular remodelling, six months after acute myocardial infarction.

Article Snippet: Day-30 Galectin-3 also showed positive correlations with echocardiography parameters indicative of diastolic and systolic dysfunction.

Techniques:

Correlation between plasma Galectin-3 levels and  echocardiography parameters  determined 6 months after acute myocardial infarction.

Journal: Scientific Reports

Article Title: Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction

doi: 10.1038/s41598-019-49511-4

Figure Lengend Snippet: Correlation between plasma Galectin-3 levels and echocardiography parameters determined 6 months after acute myocardial infarction.

Article Snippet: Day-30 Galectin-3 also showed positive correlations with echocardiography parameters indicative of diastolic and systolic dysfunction.

Techniques: Clinical Proteomics